Topiramate Tablet, Film Coated
Product Images NDC 71335-1143
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 71335-1143). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Structured Product Formula For Topiramate (39703b05 F774 4aed 9792 000a61531553 02)
This is a graph displaying cumulative rates for time to first seizure in patients administered with Topiramate 50 mg/day (N = 234) and Topiramate 400 mg/day (N = 236). It shows the probability of experiencing a seizure during different time intervals and indicates that the group taking Topiramate 400 mg/day has a significantly lower rate of seizures.*
Topiramate Tablets Usp (39703b05 F774 4aed 9792 000a61531553 03)
Label (Lbl713351143)
The packaging information indicates that the medicine, Topiramate, in the form of white round tablets, has been prepacked by Bryant Ranck Prepack Bunbauk in the quantity of 60 tablets per package. Each 100mg tablet is meant to be stored at room temperature, specifically between 20°C-25°C (68°F-77°F), and should be kept out of the reach of children. The National Drug Code (NDC) for this pharmaceutical item is 7133511431, and the expiration date is not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.